Thomas Laufer
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- RNA Research and Splicing
- Advanced biosensing and bioanalysis techniques
Papers in
-
- Extracellular vesicles in disease 2
- Molecular Biology Techniques and Applications 2
- Genomics and Phylogenetic Studies 1
- RNA modifications and cancer 1
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 6
- Co-authors
- Mustafa Kahraman (7 shared papers)Nicole Ludwig (7 shared papers)Eckart Meese (7 shared papers)Tobias Fehlmann (7 shared papers)Andreas Keller (7 shared papers)Christina Backes (6 shared papers)Fabian Kern (4 shared papers)Matthias Rübner (1 shared paper)
In The Last Decade
Thomas Laufer
10 papers receiving 305 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 201
- Molecular Biology 230
- Hepatology 13
- Oncology 44
- Immunology 27
Countries citing papers authored by Thomas Laufer
This map shows the geographic impact of Thomas Laufer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Laufer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Laufer more than expected).
Fields of papers citing papers by Thomas Laufer
This network shows the impact of papers produced by Thomas Laufer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Laufer. The network helps show where Thomas Laufer may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Laufer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 108 | |
| 2 | 2017 | 58 | |
| 3 | 2019 | 31 | |
| 4 | 2018 | 30 | |
| 5 | 2016 | 21 | |
| 6 | 2017 | 19 | |
| 7 | 2017 | 13 | |
| 8 | 2019 | 11 | |
| 9 | 2019 | 10 | |
| 10 | 2018 | 9 |
About Thomas Laufer
Thomas Laufer is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 10 papers that have together received 310 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (6 papers), Extracellular vesicles in disease (2 papers), Molecular Biology Techniques and Applications (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Genomics and Phylogenetic Studies (1 paper), Chronic Obstructive Pulmonary Disease (COPD) Research (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (201 citations), Molecular Biology (230 citations), Hepatology (13 citations), Oncology (44 citations) and Immunology (27 citations). Thomas Laufer has collaborated with scholars based in Germany, Italy and Finland. Frequent co-authors include Mustafa Kahraman, Nicole Ludwig, Eckart Meese, Tobias Fehlmann, Andreas Keller, Christina Backes, Fabian Kern, Matthias Rübner, Reiner Strick and Peter A. Fasching. Their work appears in journals such as Scientific Reports, Clinical Chemistry, Analytical Chemistry, Oncotarget and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.